Retatrutide 15mg

Retatrutide 15mg
$130.00
  • Significant Weight Reduction: In clinical trials, participants experienced an average body weight loss of up to 24.2% over 48 weeks, a result that rivals bariatric surgery outcomes and surpasses currently approved medications like semaglutide and tirzepatide.
  • Improved Glycemic Control: The drug significantly lowers blood sugar (HbA1c) levels and improves insulin sensitivity, making it a promising treatment for adults with type 2 diabetes.
  • Better Cardiovascular Health: Studies show that retatrutide can improve cardiovascular risk factors by reducing cholesterol, triglycerides, and blood pressure.
  • Reduced Liver Fat: It has demonstrated the ability to significantly decrease liver fat content, with more than 85% of participants with fatty liver disease (MASLD/NAFLD) achieving normal liver fat levels in a Phase 2 trial.
  • Enhanced Physical Function and Mobility: Participants in trials reported improvements in energy levels and the ability to perform physical activities. A Phase 3 trial also indicated it can substantially relieve knee pain in patients with obesity and osteoarthritis.
  • Appetite and Cravings Control: The medication helps reduce appetite and cravings by making people feel fuller faster and more in control of their eating behaviors.